Immunological determinants of human embryo implantation: an ex vivo model
Recruiting
- Conditions
- implantationinfertility100291121000021110013356
- Registration Number
- NL-OMON29908
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 280
Inclusion Criteria
IVF or ICSI treatment
Exclusion Criteria
None
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The surplus embryos will be cultured on a layer of endometrial stromal cells.<br /><br>The process of adhesion and invasion will be closely followed by measurements<br /><br>of cytokine and trophic factors in culture media, which will provide<br /><br>information on stromal invasion. Main study parameters will be the extent of<br /><br>trophoblast invasion and the cytokine and trophic factor profile of daily<br /><br>produced affluent. Study endpoint will be day 10 of embryo development. </p><br>
- Secondary Outcome Measures
Name Time Method <p>- The correlation of cytokine/trophic factor patterns expressed in (autologous<br /><br>co-) culture media from normal and abnormal stromal invading embryos.<br /><br>- To investigate whether the chromosomal constitution of the embryo is related<br /><br>to a specific pattern of cytokine expression and implantation.</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What immune cell subsets (e.g., Th17, Treg) influence embryo implantation in ex vivo models?
How do cytokine profiles (IL-10, TNF-α) correlate with successful implantation in infertile patients?
What HLA-G or integrin biomarkers predict response to immunomodulatory IVF treatments?
Are ex vivo immune modulation studies comparable to in vivo implantation success rates in infertility?
What adverse immune responses are associated with assisted reproductive technologies and how are they managed?